3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Squamous Intraepithelial Lesions
1
Prostatic Neoplasms
1
Liver Diseases
1
Interventions
trifluridine tipiracil drug combination
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
linifanib
1
ledipasvir, sofosbuvir drug combination
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
avelumab
1
atezolizumab
1
Trabectedin
1
Sorafenib
1
Ramucirumab
1
Irinotecan
1
Immunotherapy
1
Electroporation
1
Dexamethasone
1
Bevacizumab
1
Azacitidine
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Liver Diseases
×
Electroporation
×
Clear all
NCT07191548
2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA
Not yet recruiting
50 enrolled